ArticleNature communications2026
K-MARVEL: K-Mer-based antimicrobial resistance virtual exploration lab.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The rapid spread of antimicrobial resistance (AMR) necessitates new computational surveillance tools. Current methods for analysis of next-generation sequencing data have trade-offs: assembly-based approaches are computationally intensive, and direct long-read mapping is hampered by high error rates that obscure resistance-conferring mutations. Here, we present K-MARVEL, an open-source method that captures antimicrobial resistance genes (ARGs) and resistance-conferring mutations from both short- and long-read datasets. Operating in protein k-mer space, K-MARVEL tolerates nucleotide-level sequencing errors. We benchmarked K-MARVEL on 209 long-read and 205 short-read datasets across 22 bacterial species and achieved F1-scores of 0.976 (short-read) and 0.958 (long-read), outperforming assembly-based methods in speed and memory usage. K-MARVEL had higher F1-scores than seven widely used short-read-based ARG classifiers (0.979) and two widely used long-read-based classifiers (0.961) for homology-model-based ARGs. K-MARVEL can accurately identify both homologous ARGs and structural genes containing resistance-conferring mutations, including multiple variants, directly from raw sequencing data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.